Predictive oncology adjourns annual meeting of stockholders to december 30, 2021

Minneapolis, dec. 27, 2021 (globe newswire) -- predictive oncology (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence (“ai”) to personalized medicine and drug discovery, announced today that the company's annual meeting of stockholders was convened at 3:00 p.m. central time on december 23, 2021 and was immediately adjourned due to lack of the required quorum. a quorum was not achieved because there were fewer than a majority of outstanding shares entitled to vote, either present in person or represented by proxy, at the annual meeting. the annual meeting was adjourned to 3:00 p.m. central time on thursday, december 30, 2021 at 3300 wells fargo center, 90 south seventh street, minneapolis, mn 55402 to allow additional time for the company's stockholders to vote on the proposals set forth in the company's definitive proxy statement filed with the securities and exchange commission on november 5, 2021. during the period of adjournment, the company will continue to solicit votes from its stockholders with respect to the proposals set forth in the proxy statement.
POAI Ratings Summary
POAI Quant Ranking